- Home
- NCRA vs IMNN Comparison
NCRA vs IMNN Comparison
Compare NCRA & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- IMNN
- Stock Information
- Founded
- NCRA 2002
- IMNN 1982
- Country
- NCRA Taiwan
- IMNN United States
- Employees
- NCRA N/A
- IMNN N/A
- Industry
- NCRA Farming/Seeds/Milling
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- IMNN Health Care
- Exchange
- NCRA Nasdaq
- IMNN Nasdaq
- Market Cap
- NCRA 16.1M
- IMNN 12.9M
- IPO Year
- NCRA N/A
- IMNN 1985
- Fundamental
- Price
- NCRA $1.01
- IMNN $3.77
- Analyst Decision
- NCRA
- IMNN Buy
- Analyst Count
- NCRA 0
- IMNN 2
- Target Price
- NCRA N/A
- IMNN $182.61
- AVG Volume (30 Days)
- NCRA 1.9M
- IMNN 56.4K
- Earning Date
- NCRA 11-14-2025
- IMNN 11-13-2025
- Dividend Yield
- NCRA N/A
- IMNN N/A
- EPS Growth
- NCRA N/A
- IMNN N/A
- EPS
- NCRA N/A
- IMNN N/A
- Revenue
- NCRA $14,106,275.00
- IMNN N/A
- Revenue This Year
- NCRA N/A
- IMNN N/A
- Revenue Next Year
- NCRA N/A
- IMNN N/A
- P/E Ratio
- NCRA N/A
- IMNN N/A
- Revenue Growth
- NCRA N/A
- IMNN N/A
- 52 Week Low
- NCRA $0.70
- IMNN $3.56
- 52 Week High
- NCRA $2.40
- IMNN $41.22
- Technical
- Relative Strength Index (RSI)
- NCRA 34.29
- IMNN 35.44
- Support Level
- NCRA $0.94
- IMNN $3.56
- Resistance Level
- NCRA $1.14
- IMNN $4.38
- Average True Range (ATR)
- NCRA 0.12
- IMNN 0.30
- MACD
- NCRA -0.02
- IMNN 0.00
- Stochastic Oscillator
- NCRA 17.74
- IMNN 21.95
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).